Teach a Man to Make Drugs: Pharmaceutical Companies Invest in African Generic Drug Plant Teach a Man to Make Drugs: Pharmaceutical Companies Invest in African Generic Drug Plant
The GOOD Life

Teach a Man to Make Drugs: Pharmaceutical Companies Invest in African Generic Drug Plant

by Ann Marie Gardner

February 7, 2011

Business Week reports that India's Cipla corporation in conjunction with Quality Chemicals Industries Ltd., a Ugandan pharmaceuticals manufacturer, is planning an $80 million expansion to their current operations in Uganda. This expansion will expand their capacity to produce generic AIDS and malaria medication:

The East African nation has about 442,000 people in need of generic AIDS drugs and only 218,900 have access to the treatment because of financial constraints, Uganda AIDSs Commission data shows. Quality Chemicals’ plant in Kampala has the capacity to produce 6 million malaria or generic AIDS tablets daily, with room for expansion, according to the company.

According to the World Health Organization, the number of people infected with HIV in Uganda has increased from 6.1 percent five years ago to 7.1 percent of the population today. The increase in productive capacity in Kampala has the ability to help millions in need of vital medication. 

Image: Pills., a Creative Commons Attribution (2.0) image from 59334544@N00's photostream

+
Join the discussion
Recently on GOOD
The
Daily
GOOD
Sign up to receive the best of GOOD delivered to your inbox each and every weekday
Artist turns internet provider's boring electrical boxes into wildly fun art http://t.co/XeIh1Qd6H4 http://t.co/gkXfSYYzib
Teach a Man to Make Drugs: Pharmaceutical Companies Invest in African Generic Drug Plant